These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 440154)
41. [Antiviral activity of remantadine evaluated by a pathomorphological study of the lungs of mice infected by influenza virus]. Denys A; Korczak E; Kulig A; Błoch P; Sygut J Med Dosw Mikrobiol; 1984; 36(4):231-8. PubMed ID: 6535053 [No Abstract] [Full Text] [Related]
42. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine]. Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040 [TBL] [Abstract][Full Text] [Related]
43. Combined effect of selected antiviral substances of natural and synthetic origin. II. Anti-influenza activity of a combination of a polyphenolic complex isolated from Geranium sanguineum L. and rimantadine in vivo. Gegova G; Manolova N; Serkedzhieva Iu; Maksimova V; Uzunov S; Dzeguze D; Indulen M Acta Microbiol Bulg; 1993; 30():37-40. PubMed ID: 8285131 [TBL] [Abstract][Full Text] [Related]
44. Bis-basic-substituted polycyclic aromatic compounds. A new class of antiviral agents. 1,2 6. Bis-basic-substituted fluoranthenes. Albrecht WL; Fleming RW; Horgan SW; Deck BA; Hoffman JW; Mayer GD J Med Chem; 1974 Nov; 17(11):1150-6. PubMed ID: 4369817 [No Abstract] [Full Text] [Related]
45. Adamantane derivatives of biological interest. Synthesis and antiviral activity of 2-(1-adamantyl)imidazole derivatives. Pellicciari R; Fioretti MC; Cogolli P; Tiecco M Arzneimittelforschung; 1980; 30(12):2103-5. PubMed ID: 7194068 [TBL] [Abstract][Full Text] [Related]
46. Adamantylamphetamines: evaluation of their activity on the central nervous system. De Angelis L; Traversa U; Vertua R Farmaco Prat; 1976 May; 31(5):227-37. PubMed ID: 1269731 [No Abstract] [Full Text] [Related]
47. Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model. Bantia S; Kellogg D; Parker CD; Babu YS Antiviral Res; 2010 Dec; 88(3):276-80. PubMed ID: 20943201 [TBL] [Abstract][Full Text] [Related]
48. [Chemotherapeutic activity of bonafton in experimental herpetic keratitis in rabbits]. Bogdanova NS; Nikolaeva IS; Pershin GN Farmakol Toksikol; 1975; 38(6):728-32. PubMed ID: 1227924 [TBL] [Abstract][Full Text] [Related]
49. Structure-antitumor activity relationships among quinone derivatives. Driscoll JS; Hazard GF; Wood HB; Goldin A Cancer Chemother Rep 2; 1974 Apr; 4(2):1-362. PubMed ID: 4856629 [No Abstract] [Full Text] [Related]
50. Rimantadine therapy of influenza A infection in mice. Rabinovich S Antimicrob Agents Chemother; 1972 May; 1(5):408-11. PubMed ID: 4670482 [TBL] [Abstract][Full Text] [Related]
51. [Experimental model of inhalation influenza infection for evaluation of the effectiveness of anti-influenza preparations]. D'iakov SI; Misnikov OP; Chizhov NP Vopr Virusol; 1989; 34(6):746-9. PubMed ID: 2633469 [No Abstract] [Full Text] [Related]
52. Antiviral compounds. XII. Antiviral activity of amidinohydrazones of alkoxyphenyl-substituted carbonyl compounds against influenza virus in eggs and in mice. Nishimura T; Toku H; Fukuyasu H Kitasato Arch Exp Med; 1977 Jun; 50(1-2):39-46. PubMed ID: 616473 [No Abstract] [Full Text] [Related]
53. [The anti-influenza effect of rimantadine and isoprinosine when used in combination in mice]. Pancheva S; Gegova G; Maksimova V; Manolova N Acta Microbiol Bulg; 1990; 26():26-9. PubMed ID: 1711269 [TBL] [Abstract][Full Text] [Related]
54. [Pathomorphological study of antiviral chemotherapeutic effectiveness of bonaphthon under experimental conditions]. Nikolaeva IS; Kutchak SN; Bogdanova NS; Pershin GN Farmakol Toksikol; 1976; 39(3):336-41. PubMed ID: 1026519 [TBL] [Abstract][Full Text] [Related]
55. [Inhibitory effect of alpha-methyl-1-adamantane methylamine hydrochloride (rimantadine) on RNA-dependent RNA polymerase induction in culture of cells, infected with influenza virus]. Galegov GA; Iatsyna AA; Linitskaia GL; Pushkarskaia NL Biokhimiia; 1976 Dec; 41(12):2237-9. PubMed ID: 1022284 [TBL] [Abstract][Full Text] [Related]
56. [Remantadine and 4-iodoantipyrine in the treatment and prevention of experimental influenza infection]. Evstropov AN; Iavorovskaia VE; Galegov GA Vopr Virusol; 1989; 34(6):734-8. PubMed ID: 2483783 [No Abstract] [Full Text] [Related]
57. [Effect of remantadine on the development of toxicoses caused by different strains of influenza virus]. Kiseleva IV Vopr Virusol; 1981; (5):541-3. PubMed ID: 7336681 [TBL] [Abstract][Full Text] [Related]
58. [Synthesis and in vitro virucidal effect of recent 1-substituted adamantane derivatives]. Sztaricskai F; Pelyvás I; Dinya Z; Szilágyi L; Györgydeák Z; Hadházy G; Váczi L; Bognár R Pharmazie; 1975 Sep; 30(9):571-81. PubMed ID: 1187737 [No Abstract] [Full Text] [Related]
59. [Evaluation of the preventive effectiveness in influenza of the new native antiviral chemical agent oxoline in the 1969 epidemics]. Aksenov VA; Selidovkin DA; Gladkikh GN; Grakhova AG; Bogdanova NS Farmakol Toksikol; 1970; 33(6):726-33. PubMed ID: 4932223 [No Abstract] [Full Text] [Related]